Investorideas.com newswire, breaking biotechnology and pharma news

Thursday, November 19, 2020

#MedicalTechnology #Stock News - Electromedical Technologies (OTCQB: $EMED) Produces $4.2 Million in Device Inventory to Meet Demand; @ElectromedicalT

 

#MedicalTechnology #Stock News - Electromedical Technologies (OTCQB: $EMED) Produces $4.2 Million in Device Inventory to Meet Demand; @ElectromedicalT

 

Company completes production of 1,200_FDA-cleared WellnessPro+ devices

 

Inventory build completed ahead of on-boarding new medical practitioners and distributors

 

Demand driven by pain sufferers desire to find non-invasive alternatives 

 


SCOTTSDALE, AZ, November 19, 2020 (Investorideas.com Newswire) – Breaking Medical Technology stock news - Electromedical Technologies, Inc. (OTCQB: EMED ) (the "Company"), a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared WellnessPro+, designed to relieve chronic, intractable and acute pains by using frequencies and electro-modulation, is pleased to announce that the company has completed the production of over 1,200 units of its FDA cleared WellnessPro+ device, representing approximately $4.2 million of inventory to meet demand.

 

Read this news featuring EMED in full at https://www.investorideas.com/news/2020/biotech/11191EMED-Device-Inventory.asp

 

The Company began production in September and has fully paid for and completed its first phase of inventory buildup in order to meet rising demand as we transition into 2021. We want to make sure that we do not run out of inventory which occurred in the first quarter of this year.

 

Matthew Wolfson, Founder and CEO of EMED, commented, “Every day more doctors and patients are realizing the importance of using methods that will have a positive effect in reducing pain without having negative effects on the immune system, especially in today’s pandemic environment. The reason for the increase in demand is that more and more people are realizing that there are other powerful treatment options such as bioelectronics, that does not include injections, invasive procedures or opioids that have the possibility of harmful side effects such as addiction and death.”

 

Commenting further, Mr. Wolfson said, “This inventory increase fits perfectly with our strategic plan of engaging and onboarding hundreds of new medical practitioners and distributors. In today’s economic environment, many people are seeking to create new revenue streams for their families. We have a way to help thousands of people to live a better quality of life, pain free and addiction free and at the same time provide a real income opportunity for anyone who wishes to join our brand ambassador team.”  (https://electromedtech.com/register/)

 

Finally commenting, Mr. Wolfson said, “In the world we live in today, people cannot afford the risks associated with opioid-based drugs, but they need results. Word of mouth has been a very valuable marketing tool because our device delivers a powerful solution to chronic pain without any dangerous or harmful side effects. The Wellness Pro produces real results so people can live pain free and get their lives back!”

 

About Electromedical Technologies

Headquartered in Scottsdale Arizona, Electromedical Technologies, Inc. is a commercial stage, FDA cleared, bioelectronic medical device manufacturing company initially focused on the treatment of various chronic, acute, intractable, and post-operative pain conditions. Through university collaboration agreements the company is working to develop a comprehensive research program in defining the effects of electro-modulation on the human body by studying the impacts of electrical fields in cell signaling and effects on virus assembly and immune responses with the goal of improving human wellbeing. The company’s current cleared product indications are for chronic acute post traumatic and post-operative, intractable pain relief.

 

Our animal studies do not involve any human testing, and are not related to our current products. We are conducting this research to augment and advance the science of electro-modulation in healthcare.  The United States Food and Drug Administration has not reviewed or approved our animal research studies

 

For more information, visit www.electromedtech.com.

 

Safe Harbor Statement

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.

 

Corporate Contact:

Electromedical Technologies, Inc.
Matthew Wolfson
Tel: 1.888.880.7888
email:
ceo@electromedtech.com
https://electromedtech.com

 

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring Electromedical Technologies, Inc. (OTCQB: EMED)  is a paid for news release on Investorideas.com  More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

About Investorideas.com

https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 


BiotechIndustryStocks.com - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks

 

 

Tuesday, November 10, 2020

New #Sanitation and #PPE Products come to market in anticipation of rise in demand (OTC: $HIPH) (OTC: $OPTI) (OTC: $ATWT) (OTC: $RLLVF) @AmericanPremium @optecfuelintl @AtwecTech @RELEVIUMCORP #COVID19 #Coronavirus

 

New #Sanitation and #PPE Products come to market in anticipation of rise in demand (OTC: $HIPH) (OTC: $OPTI) (OTC: $ATWT) (OTC: $RLLVF) @AmericanPremium @optecfuelintl @AtwecTech @RELEVIUMCORP #COVID19 #Coronavirus

 

Point Roberts WA, Delta, BC – November 10, 2020 - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a special report on the continued growth of the sanitation and PPE sectors as businesses around the world look to supply the new COVID reality and prepare for a potential second wave.

 

Read this news, featuring HIPH in full at https://www.investorideas.com/news/2020/main/11101Sanitation-PPE-Products.asp

 

While COVID-19 has impacted many businesses both negatively and positively, as we enter into the colder seasons many companies are using this time to bring new sanitation and PPE products to market in anticipation of another rise in demand as well as to help prevent further spread of the pandemic.

 

American Premium Water Corporation (OTC: HIPH) recently announced that it has begun production on the first run of proprietary nano-infused products through its distribution agreement with BioHealth Water Inc., a wholly owned subsidiary of Alset International Limited (SGX:40V). The initial production run marks the beginning of the Company’s efforts to sell its aerosolized sanitizing machines in addition to its two new products utilizing its proprietary Hydro Nano technology: Nano Energy Water and Nitrous Oxide Shots. The products are in the process of applications for product distribution in Malaysia, Hong Kong, Taiwan, Singapore, USA and Canada.

 

Ryan Fishoff, CEO of American Premium Water commented, “I am excited to announce the beginning of production for our new products with our new partner in BioHealth Water. This first run will get the products into the hands of distributors across the Pacific Rim (North America & Asia). We are only scratching the surface of the potential that we have with BioHealth Water and I look forward to receiving feedback from our distributors as we prepare for full scale production later this year. Our plans to increase the volume of distribution alongside various other initiatives that we intend to achieve in the remaining quarter of 2020 will set a firm platform for us to move full steam into 2021. As I have been emphasizing over the years, I believe this partnership highlights the value of the Company’s Hydro Nano technology. We are exploring even more ways to unlock value from this technology, and I look forward to sharing these developments with shareholders in the coming weeks and months.”

 

The Company previously announced in April that it had developed a prototype of an aerosolized sanitizing machine using its proprietary Hydro Nano technology. This production run will be the first run of the devices and its accompanying sanitizing nano-solution. All products will be sold through HWH global distributors (www.hwhworld.com) and direct sales in the respective countries.

 

Chan Heng Fai, Chairman and CEO of Alset commented, “I am very excited to begin selling these products across our global distribution channels. All three products have the potential to make an extraordinary impact that I believe will translate well to the consumer and drive sales. I see a tremendous opportunity with the sanitizing machine to assist small businesses that are looking for an effective solution to bring customers back through the door. I am also looking forward to bringing Nano Energy Water to market, which I believe will make a big impact with customers. I look forward to working with Ryan and his team to continue growing distribution and bring even more impactful products to market in the coming years.”

 

OPTEC International, Inc (OTC:OPTI) announced recently that it has successfully secured a fully executed definitive agreement for the supply of Brand Specific Personal Protection Equipment (PPE) products for a large International Commodities Consortium totaling in excess of $2 Billion Dollars US.

 

OPTEC CEO, Roger Pawson commented "The company has been working for over a month to bring the transaction to successful closing and we are extremely happy to announce the execution of the definitive agreement and preparation of the massive logistics operation for the distribution of the products, furthermore OPTEC has entered into an additional agreement with an established Freight and Logistics organization for the transportation of products to the final destinations in the Healthcare, Medical, and Hospital sectors.

 

Item 1.01 Entry into A Material Definitive Agreement.

  1. If the registrant has entered into a material definitive agreement not made in the ordinary course of business of the registrant, or into any amendment of such agreement that is material to the registrant, disclose the following information:

 

On October 30, 2020 the Company (OPTEC) entered into a definitive agreement with a large International Commodities Consortium for the supply and distribution of Specific Brands of Personal Protection Equipment (PPE) for Medical & Hospital use throughout North America, totaling in excess of Two Billion Dollars $US. The agreement has been fully executed by the company and the buyer, along with proofed bank certified funds to complete the transaction in excess of $2 Billion Dollars US. The company (OPTEC) has already sourced and secured the products for the entire agreement, along with coordinating the logistics portion of the agreement. The product distribution is expected to be fully completed by December 2020.

 

Another company based in health and wellness like American Premium Water, Relevium Technologies Inc. (TSX.V: RLV) (OTC: RLLVF), announced in September that its wholly-owned subsidiary in the US, BGX E-Health LLC, had secured up to eight chartered flights to deliver USD$16.9 Million of critical PPE to the Canadian Health Care Market, which arrived over the next 7-10 days in Canada.

 

On September 17, 2020, the Company announced it had secured an initial contract totaling USD$20 million of critical PPE aimed for the Canadian healthcare market. The Company is now focused on the delivery of this initial contract, as we all, on pursuing new opportunities in the space.

 

This initial delivery represented approximately 75% of the initial previously announced contract.

 

BGX E-Health, the Company’s US wellness subsidiary has pivoted into the Emergency Segment of the Health and Wellness market by launching its own line of hand sanitizers and developing air purifier solutions. In the early summer months of this year, the Company identified an opportunity to make a difference in the supply of critical PPE and on July 13, 2020 the company announced a joint venture between Relevium and H-Source to join forces to bring critical PPE to the areas in need in a secure and traceable platform.

 

Aurelio Useche, CEO of Relevium stated, “Our team has been on site in the US sourcing both, local and overseas supplies of critical PPE and we are pleased to announce the scheduling of several airfreight charts to deliver the urgently products on a timely basis. We now set our sights on further development of this space as we expand our customer base in conjunction with our partners.”

 

This industry is attracting attention from businesses from all sectors. Even child safety and security company, ATWEC Technologies (OTC: ATWT) announced that it is giving transportation companies and passengers yet another layer of protection. The company has introduced the KV-X Sterilization System, a new automated, two-stage sterilization system for school buses, daycare vans, and other commercial vehicles that kills germs, viruses, and bacteria in the air and on vehicle surfaces quickly, safely and effectively.

 

Built for 15-passenger vehicles or larger, the KV-X features a 30-minute, two-stage sanitization module that adheres to all FDA guidelines. When the KV-X system is initiated, a built-in induction fan draws air through an easily replaceable HEPA filter and into a self-contained ultraviolet light (UVC) to disinfect the air within the vehicle. During the next stage, ozone is generated to clean seats, door handles, and other high-touch internal surfaces. UVC and ozone have been scientifically tested and used for years to kill airborne and surface germs and viruses.

 

The KV-X comes with a built-in timer, enabling users to schedule the system to self-start at a pre-designated time, typically overnight, to ensure vehicles are properly sanitized for next-day use. An always-on motion sensor (the same technology that powers ATWEC's KV-4 Child Reminder System) confirms a vehicle is empty before the KV-X sterilization cycle can begin. If the KV-X detects motion during the cycle, it will immediately shut down the system to prevent direct passenger exposure to the ozone and UVC.

 

"When it comes to transportation, our mission is to ensure the safest ride for each child, passenger and driver. In today's environment, expanding our product line into vehicle sanitization was obvious," said Darnell Stitts, President and CEO at ATWEC Technologies. "The KV-X Sterilization System is a safe, fast, and efficient way for school systems, daycare organizations, commercial transportation services, and even public transportation agencies to give passengers and their families peace of mind and a cleaner, healthier riding experience."

 

The KV-X can be installed in any 15-passenger vehicle or larger. It is more efficient than traditional manual aerosol mist applications and it does not rely on a vehicle's air conditioning system to operate. This process allows the vehicle to be sanitized quickly and be back into operation sooner.

 

As governments around the world struggle to provide adequate sanitation and PPE equipment to hospitals and essential workers, the public sector continues to capitalize on this market growth opportunity and through new innovations is helping to ensure that customers have access to adequate sanitation and PPE equipment in a post COVID world.

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others. 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: this news article featuring HIPH is a paid for news release on Investorideas.com –More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800-665-0411

Monday, November 9, 2020

#COVID19 Second Wave? From #Sanitizers to #PPE’s, Companies are Preparing (OTC: $HIPH) (OTC: $OPTI) (OTC: $ATWT) (OTC: $RLLVF) @AmericanPremium @optecfuelintl @AtwecTech @RELEVIUMCORP

#COVID19 Second Wave? From #Sanitizers to #PPE’s, Companies are Preparing (OTC: $HIPH) (OTC: $OPTI) (OTC: $ATWT) (OTC: $RLLVF) @AmericanPremium @optecfuelintl @AtwecTech @RELEVIUMCORP

 


Point Roberts WA, Delta, BC – November 9, 2020 - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a special report on the continued growth of the sanitation and PPE sectors as businesses around the world look to supply the new COVID reality and prepare for a potential second wave.

 

Read this news, featuring HIPH in full at https://www.investorideas.com/news/2020/main/11091COVID-19-Second-Wave.asp

 

While COVID-19 has impacted many businesses both negatively and positively, as we enter into the colder seasons many companies are using this time to bring new sanitation and PPE products to market in anticipation of another rise in demand as well as to help prevent further spread of the pandemic.

 

American Premium Water Corporation (OTC: HIPH) recently announced that it has begun production on the first run of proprietary nano-infused products through its distribution agreement with BioHealth Water Inc., a wholly owned subsidiary of Alset International Limited (SGX:40V). The initial production run marks the beginning of the Company’s efforts to sell its aerosolized sanitizing machines in addition to its two new products utilizing its proprietary Hydro Nano technology: Nano Energy Water and Nitrous Oxide Shots. The products are in the process of applications for product distribution in Malaysia, Hong Kong, Taiwan, Singapore, USA and Canada.

 

Ryan Fishoff, CEO of American Premium Water commented, “I am excited to announce the beginning of production for our new products with our new partner in BioHealth Water. This first run will get the products into the hands of distributors across the Pacific Rim (North America & Asia). We are only scratching the surface of the potential that we have with BioHealth Water and I look forward to receiving feedback from our distributors as we prepare for full scale production later this year. Our plans to increase the volume of distribution alongside various other initiatives that we intend to achieve in the remaining quarter of 2020 will set a firm platform for us to move full steam into 2021. As I have been emphasizing over the years, I believe this partnership highlights the value of the Company’s Hydro Nano technology. We are exploring even more ways to unlock value from this technology, and I look forward to sharing these developments with shareholders in the coming weeks and months.”

 

The Company previously announced in April that it had developed a prototype of an aerosolized sanitizing machine using its proprietary Hydro Nano technology. This production run will be the first run of the devices and its accompanying sanitizing nano-solution. All products will be sold through HWH global distributors (www.hwhworld.com) and direct sales in the respective countries.

 

Chan Heng Fai, Chairman and CEO of Alset commented, “I am very excited to begin selling these products across our global distribution channels. All three products have the potential to make an extraordinary impact that I believe will translate well to the consumer and drive sales. I see a tremendous opportunity with the sanitizing machine to assist small businesses that are looking for an effective solution to bring customers back through the door. I am also looking forward to bringing Nano Energy Water to market, which I believe will make a big impact with customers. I look forward to working with Ryan and his team to continue growing distribution and bring even more impactful products to market in the coming years.”

 

OPTEC International, Inc (OTC:OPTI) announced recently that it has successfully secured a fully executed definitive agreement for the supply of Brand Specific Personal Protection Equipment (PPE) products for a large International Commodities Consortium totaling in excess of $2 Billion Dollars US.

 

OPTEC CEO, Roger Pawson commented "The company has been working for over a month to bring the transaction to successful closing and we are extremely happy to announce the execution of the definitive agreement and preparation of the massive logistics operation for the distribution of the products, furthermore OPTEC has entered into an additional agreement with an established Freight and Logistics organization for the transportation of products to the final destinations in the Healthcare, Medical, and Hospital sectors.

 

Item 1.01 Entry into A Material Definitive Agreement.

  1. If the registrant has entered into a material definitive agreement not made in the ordinary course of business of the registrant, or into any amendment of such agreement that is material to the registrant, disclose the following information:

 

On October 30, 2020 the Company (OPTEC) entered into a definitive agreement with a large International Commodities Consortium for the supply and distribution of Specific Brands of Personal Protection Equipment (PPE) for Medical & Hospital use throughout North America, totaling in excess of Two Billion Dollars $US. The agreement has been fully executed by the company and the buyer, along with proofed bank certified funds to complete the transaction in excess of $2 Billion Dollars US. The company (OPTEC) has already sourced and secured the products for the entire agreement, along with coordinating the logistics portion of the agreement. The product distribution is expected to be fully completed by December 2020.

 

Another company based in health and wellness like American Premium Water, Relevium Technologies Inc. (TSX.V: RLV) (OTC: RLLVF), announced in September that its wholly-owned subsidiary in the US, BGX E-Health LLC, had secured up to eight chartered flights to deliver USD$16.9 Million of critical PPE to the Canadian Health Care Market, which arrived over the next 7-10 days in Canada.

 

On September 17, 2020, the Company announced it had secured an initial contract totaling USD$20 million of critical PPE aimed for the Canadian healthcare market. The Company is now focused on the delivery of this initial contract, as we all, on pursuing new opportunities in the space.

 

This initial delivery represented approximately 75% of the initial previously announced contract.

 

BGX E-Health, the Company’s US wellness subsidiary has pivoted into the Emergency Segment of the Health and Wellness market by launching its own line of hand sanitizers and developing air purifier solutions. In the early summer months of this year, the Company identified an opportunity to make a difference in the supply of critical PPE and on July 13, 2020 the company announced a joint venture between Relevium and H-Source to join forces to bring critical PPE to the areas in need in a secure and traceable platform.

 

Aurelio Useche, CEO of Relevium stated, “Our team has been on site in the US sourcing both, local and overseas supplies of critical PPE and we are pleased to announce the scheduling of several airfreight charts to deliver the urgently products on a timely basis. We now set our sights on further development of this space as we expand our customer base in conjunction with our partners.”

 

This industry is attracting attention from businesses from all sectors. Even child safety and security company, ATWEC Technologies (OTC: ATWT) announced that it is giving transportation companies and passengers yet another layer of protection. The company has introduced the KV-X Sterilization System, a new automated, two-stage sterilization system for school buses, daycare vans, and other commercial vehicles that kills germs, viruses, and bacteria in the air and on vehicle surfaces quickly, safely and effectively.

 

Built for 15-passenger vehicles or larger, the KV-X features a 30-minute, two-stage sanitization module that adheres to all FDA guidelines. When the KV-X system is initiated, a built-in induction fan draws air through an easily replaceable HEPA filter and into a self-contained ultraviolet light (UVC) to disinfect the air within the vehicle. During the next stage, ozone is generated to clean seats, door handles, and other high-touch internal surfaces. UVC and ozone have been scientifically tested and used for years to kill airborne and surface germs and viruses.

 

The KV-X comes with a built-in timer, enabling users to schedule the system to self-start at a pre-designated time, typically overnight, to ensure vehicles are properly sanitized for next-day use. An always-on motion sensor (the same technology that powers ATWEC's KV-4 Child Reminder System) confirms a vehicle is empty before the KV-X sterilization cycle can begin. If the KV-X detects motion during the cycle, it will immediately shut down the system to prevent direct passenger exposure to the ozone and UVC.

 

"When it comes to transportation, our mission is to ensure the safest ride for each child, passenger and driver. In today's environment, expanding our product line into vehicle sanitization was obvious," said Darnell Stitts, President and CEO at ATWEC Technologies. "The KV-X Sterilization System is a safe, fast, and efficient way for school systems, daycare organizations, commercial transportation services, and even public transportation agencies to give passengers and their families peace of mind and a cleaner, healthier riding experience."

 

The KV-X can be installed in any 15-passenger vehicle or larger. It is more efficient than traditional manual aerosol mist applications and it does not rely on a vehicle's air conditioning system to operate. This process allows the vehicle to be sanitized quickly and be back into operation sooner.

 

As governments around the world struggle to provide adequate sanitation and PPE equipment to hospitals and essential workers, the public sector continues to capitalize on this market growth opportunity and through new innovations is helping to ensure that customers have access to adequate sanitation and PPE equipment in a post COVID world.

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others. 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: this news article featuring HIPH is a paid for news release on Investorideas.com –More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800-665-0411